Benzenesulfonamides
2,4,6-Triisopropylbenzenesulfonyl Azide (wetted with ca. 10% Water) (unit weight on dry weight basis) 98.0+%, TCI America™
CAS: 36982-84-0 Molecular Formula: C15H23N3O2S Molecular Weight (g/mol): 309.428 MDL Number: MFCD00859286 InChI Key: AEMWUHCKKDPRSK-UHFFFAOYSA-N Synonym: 2,4,6-triisopropylbenzenesulfonyl azide,2,4,6-triisopropylbenzene-sulfonyl azide,trisyl azide,2,4,6-triisopropylbenzene-sulfonyl azide,,benzenesulfonyl azide, 2,4,6-tris 1-methylethyl,2,4,6-triisopropyl-benzenesulfonyl azide,n-diazo-2,4,6-triisopropyl-benzenesulfonamide,2,4,6-tris 1-methylethyl-benzenesulfonyl azide,2,4,6-triisopropylbenzenesulfonyl azide, stab. with ca water,trisyl azide solution PubChem CID: 371707 IUPAC Name: N-diazo-2,4,6-tri(propan-2-yl)benzenesulfonamide SMILES: CC(C)C1=CC(=C(C(=C1)C(C)C)S(=O)(=O)N=[N+]=[N-])C(C)C
Sulfasalazine, USP, 97-101.5%, Spectrum™ Chemical
CAS: 599-79-1 Molecular Formula: C18H14N4O5S Molecular Weight (g/mol): 398.39 InChI Key: OQANPHBRHBJGNZ-BKUYFWCQSA-N IUPAC Name: (3Z)-6-oxo-3-(2-{4-[(pyridin-2-yl)sulfamoyl]phenyl}hydrazin-1-ylidene)cyclohexa-1,4-diene-1-carboxylic acid SMILES: OC(=O)C1=C\C(C=CC1=O)=N/NC1=CC=C(C=C1)S(=O)(=O)NC1=CC=CC=N1
Sulfasalazine, USP, 97-101.5%, Spectrum™ Chemical
CAS: 599-79-1 Molecular Formula: C18H14N4O5S Molecular Weight (g/mol): 398.39 InChI Key: OQANPHBRHBJGNZ-BKUYFWCQSA-N IUPAC Name: (3Z)-6-oxo-3-(2-{4-[(pyridin-2-yl)sulfamoyl]phenyl}hydrazin-1-ylidene)cyclohexa-1,4-diene-1-carboxylic acid SMILES: OC(=O)C1=C\C(C=CC1=O)=N/NC1=CC=C(C=C1)S(=O)(=O)NC1=CC=CC=N1
Sildenafil Citrate, USP, 98-102%, Spectrum™ Chemical
CAS: 171599-83-0 Molecular Formula: C28H38N6O11S Molecular Weight (g/mol): 666.70 InChI Key: DEIYFTQMQPDXOT-UHFFFAOYSA-N IUPAC Name: 2-hydroxypropane-1,2,3-tricarboxylic acid; 5-{2-ethoxy-5-[(4-methylpiperazin-1-yl)sulfonyl]phenyl}-1-methyl-3-propyl-1H,4H,7H-pyrazolo[4,3-d]pyrimidin-7-one SMILES: OC(=O)CC(O)(CC(O)=O)C(O)=O.CCCC1=NN(C)C2=C1NC(=NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(C)CC1
Ribonucleic Acid, Spectrum™ Chemical
CAS: 63231-63-0
Enzo Life Sciences NBQX . disodium salt (25mg). CAS: 118876-58-7 (non-salt)
Water soluble, potent and selective AMPA/kainate receptor antagonist. For literature references, see NBQX (ALX-550-044). Alternative name: 2,3-Dihydroxy-6-nitro-7-sulphamoylbenzo(f)-quinoxaline . 2Na, 6-Nitro-7-sulphamoylbenzo(f)-quinoxaline-2,3-dione . 2Na. Purity: ≥98% (HPLC). Solubility: Soluble in water (5mg/ml) or DMSO. Long Term Storage: -20°C.
Enzo Life Sciences NBQX . disodium salt (5mg). CAS: 118876-58-7 (non-salt)
Water soluble, potent and selective AMPA/kainate receptor antagonist. For literature references, see NBQX (ALX-550-044). Alternative name: 2,3-Dihydroxy-6-nitro-7-sulphamoylbenzo(f)-quinoxaline . 2Na, 6-Nitro-7-sulphamoylbenzo(f)-quinoxaline-2,3-dione . 2Na. Purity: ≥98% (HPLC). Appearance: Red to brown solid. Solubility: Soluble in water (5mg/ml) or DMSO. Long Term Storage: -20°C.
Medchemexpress LLC Deltasonamide 2 hydrochloride | 2448341-55-5 | 99.8% | 5 MG
Deltasonamide 2 hydrochloride is the hydrochloride salt of Deltasonamide 2, a competitive, high-affinity inhibitor of PDEδ (phosphodiesterase delta) with a reported Kd of ~385 pM. It is supplied as a solid research reagent, soluble in DMSO and water, and intended for biochemical and cellular studies probing PDEδ function.
- High reported binding affinity to PDEδ (Kd ~385 pM).
- High purity (reported 99.78%).
- Molecular weight 683.71 g/mol and formula C30H40Cl2N6O4S2.
- Hydrochloride salt form provided as a solid.
- Soluble in DMSO and water for assay preparation.
- Suitable for biochemical and cellular research applications.
AdipoGen Glimepiride (250 mg)
Chemical. CAS: 93479-97-1. Formula: C24H34N4O5S. MW: 490.62. Glimepiride is a long-acting sulfonylurea antidiabetic agent inhibiting ATP-sensitive potassium (KATP) channels in pancreatic beta-cells, which leads to the release of insulin. In addition, Glimepiride increases the activity of intracellular insulin receptors. Studies conducted on adipocytes and skeletal muscle suggest that Glimepiride induces the PI3 kinase (PI3K) and Akt pathway, along with insulin receptor substrate-1/2 and endothelial nitric oxide synthase and stimulates glucose transporter 1 and 4 (GLUT1/4) expression. Glimepiride also increases osteoblast proliferation and differentiation, which is thought to be related to its ability to activate the PI3K and Akt pathway and exhibits neuroprotective benefit, decreasing expression and activity of BACE1 and amyloid-beta (Abeta) in neurons in a PPARgamma-dependent manner.
AdipoGen Glimepiride (1 g)
Chemical. CAS: 93479-97-1. Formula: C24H34N4O5S. MW: 490.62. Glimepiride is a long-acting sulfonylurea antidiabetic agent inhibiting ATP-sensitive potassium (KATP) channels in pancreatic beta-cells, which leads to the release of insulin. In addition, Glimepiride increases the activity of intracellular insulin receptors. Studies conducted on adipocytes and skeletal muscle suggest that Glimepiride induces the PI3 kinase (PI3K) and Akt pathway, along with insulin receptor substrate-1/2 and endothelial nitric oxide synthase and stimulates glucose transporter 1 and 4 (GLUT1/4) expression. Glimepiride also increases osteoblast proliferation and differentiation, which is thought to be related to its ability to activate the PI3K and Akt pathway and exhibits neuroprotective benefit, decreasing expression and activity of BACE1 and amyloid-beta (Abeta) in neurons in a PPARgamma-dependent manner.